Accordion to buy Merilytics, as PE firms turn to value creation

'Much of the work in private equity has shifted to portfolio company improvement,' says Michael Choe, CEO of Charlesbank, which invested in Accordion in September.

ByMary Kathleen Flynn

8 May 2023•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Featured Business services Financial Services TMT Top Stories

Accordion to buy Merilytics, as PE firms turn to value creation

Charlesbank Capital Partners

FFL Partners

Motive Partners

Related articles